Table 4.

Associations between baseline TG and WC and renal outcomes after 3-year followup.

	Model 1		Model 2		Model 3
	OR (95% CI)	p	OR (95% CI)	p	OR (95% CI)	p
eGFR <60 ml/min/1.73 m²
TG ≥1.7 mmol/l	2.44 (1.27,4.68)	.007	2.01 (1.00,4.04)	.05	1.71 (0.72,4.05)	.221
WC ≥90 cm (men) or ≥85 cm (women)	2.68 (1.25,5.75)	.012	2.66 (1.08,6.58)	.034	2.48 (0.98,6.31)	.057
UACR ≥30 mg/g
TG ≥1.7 mmol/l	1.32 (0.56,3.11)	.528	1.12 (0.78,1.60)	.552	0.71 (0.23,2.26)	.566
WC ≥90 cm (men) or ≥85 cm (women)	2.43 (0.95,6.19)	.063	1.59 (0.54,4.70)	.406	1.37 (0.45,4.18)	.579
eGFR<60 ml/min/1.73 m² and UACR ≥30 mg/g
TG ≥1.7 mmol/l	2.41 (1.28,4.56)	.007	1.88 (0.95,3.72)	.068	1.63 (0.69,3.81)	.263
WC ≥90 cm (men) or ≥85 cm (women)	2.89 (1.35,6.17)	.006	2.53 (1.03,6.19)	.042	2.35 (0.93,5.95)	.07

Model 1: Adjusted for age, sex.

Model 2: Adjusted for age, sex, TG, WC, BMI, SBP, DBP, FBG, TC.

Model 3: Adjusted for above + lipid-lowering treatment, blood-pressure-lowering treatment, antidiabetic treatment.